Twenty years of experience with less radical fertility-sparing surgery in early-stage cervical cancer: Oncological outcomes

被引:12
|
作者
Hruda, Martin [1 ,4 ]
Robova, Helena [1 ]
Rob, Lukas [1 ]
Halaska, Michael J. [1 ]
Drozenova, Jana [2 ]
Pichlik, Tomas [1 ]
Malikova, Hana [3 ]
机构
[1] Charles Univ Prague, Med Fac 3, Dept Obstet & Gynaecol, Ruska 84, Prague 10034 10, Czech Republic
[2] Charles Univ Prague, Dept Pathol, Med Fac 3, Prague, Czech Republic
[3] Charles Univ Prague, Dept Radiol, Med Fac 3, Prague, Czech Republic
[4] Charles Univ Prague, Fac Med Plzen, Dept Obstet & Gynaecol, Prague, Czech Republic
关键词
Cervical cancer; Less radical fertility-sparing surgery; Oncological outcomes; Sentinel lymph node mapping; VAGINAL TRACHELECTOMY; LYMPHADENECTOMY; CONIZATION; CARCINOMA; THERAPY; SERIES;
D O I
10.1016/j.ygyno.2021.07.031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction. The standard procedure in cervical cancer is radical hysterectomy (RH) and pelvic lymphade-nectomy (PLND). Because of the increasing age of women at childbirth, fertility becomes a major challenge. We present 20 years of experience with two-step less radical fertility-sparing surgery in women with IA1, LVSI positive, IA2 and IB1 (<2 cm, infiltration less than half of stromal invasions. Materials and method. Preoperative workout consisted of histopathological diagnosis and magnetic resonance imaging along with ultrasonographic volumetry. We then performed laparoscopic sentinel lymph node mapping (SLNM) with frozen section (FS) followed by PLND and "selective parametrectomy" (removal of afferent lym-phatic channels from the paracervix) in case of a negative result. If verified by definitive histopathology, patients were treated by simple trachelectomy (IB1) or large cone (IA1/IA2) biopsy 1 week after primary surgery. Results. From 1999 to 2018, 91 women were enrolled in the study (median age 29.1 years, range 21-40). Of these 91 women, 51 (56.0%) were nulliparous. The detection rate of SLNs was 100% per patient and the specific side detection rate 96.7%. Positive lymph nodes were diagnosed in nine cases (9.8%). These women then underwent RH. Fertility was spared in 80 women but 4 recurred locally (5.0%). The mortality rate was 0.0%. The median follow-up was 149 months. Conclusion. Less radical fertility-sparing surgery with SLNM is safe in cervical cancers <2 cm at the largest di-ameter and infiltrating less than half of the cervical stroma. The recurrence rate is acceptable with no mortality. Morbidity with this procedure is low. Extended and accurate follow-up is necessary and human papillomavirus - high risk (HPV-HR tests seem to be useful in such follow-up assessment. (c) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:100 / 104
页数:5
相关论文
共 50 条
  • [41] The functional reconstruction of fertility-sparing radical abdominal trachelectomy for early stage cervical carcinoma
    Yao, Tingting
    Mo, Shaomin
    Lin, Zhongqiu
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2010, 151 (01) : 77 - 81
  • [42] Type II Versus Type III Fertility-Sparing Abdominal Radical Trachelectomy for Early-Stage Cervical Cancer A Comparison of Feasibility of Surgical Outcomes
    Muraji, Miho
    Sudo, Tamotsu
    Nakagawa, Eriko
    Ueno, Sayaka
    Wakahashi, Senn
    Kanayama, Seiji
    Yamada, Takashi
    Yamaguchi, Satoshi
    Fujiwara, Kiyoshi
    Nishimura, Ryuichiro
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (03) : 479 - 483
  • [43] The validity of the subsequent pregnancy index score for fertility-sparing trachelectomy in early-stage cervical cancer
    Iwata, Takashi
    Machida, Hiroko
    Matsuo, Koji
    Okugawa, Kaoru
    Saito, Tsuyoshi
    Tanaka, Kyoko
    Morishige, Kenichiro
    Kobayashi, Hiroaki
    Yoshino, Kiyoshi
    Tokunaga, Hideki
    Ikeda, Tomoaki
    Shozu, K. Makio
    Yaegashi, Nobuo
    Enomoto, Takayuki
    Mikami, Mikio
    FERTILITY AND STERILITY, 2021, 115 (05) : 1250 - 1258
  • [44] Fertility-Sparing Treatment for Young Patients with Early-Stage Cervical Cancer: A Dawn of a New Era
    Theofanakis, Charalampos
    Koulakmanidis, Aristotelis-Marios
    Prodromidou, Anastasia
    Haidopoulos, Dimitrios
    Rodolakis, Alexandros
    Thomakos, Nikolaos
    FRONTIERS IN SURGERY, 2022, 9
  • [45] Less radical surgery for early-stage cervical cancer: a systematic review
    Wu, Jenny
    Logue, Teresa
    Kaplan, Samantha J.
    Melamed, Alexander
    Tergas, Ana I.
    Khoury-Collado, Fady
    Hou, June Y.
    St Clair, Caryn M.
    Hershman, Dawn L.
    Wright, Jason D.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (04) : 348 - 358
  • [46] Fertility-sparing surgery and fertility preservation in cervical cancer: The desire for parenthood, reproductive and obstetric outcomes
    van der Plas, R. C. J.
    Bos, A. M. E.
    Jurgenliemk-Schulz, I. M.
    Gerestein, C. G.
    Zweemer, R. P.
    GYNECOLOGIC ONCOLOGY, 2021, 163 (03) : 538 - 544
  • [47] Reproductive outcomes after fertility-sparing surgery for cervical cancer - results of the multicenter FERTISS study
    Fricova, Lenka
    Kommoss, Stefan
    Scambia, Giovanni
    Ferron, Gwenael
    Kocian, Roman
    Harter, Philipp
    Anchora, Luigi Pedone
    Bats, Anne-Sophie
    Novak, Zoltan
    Walter, Christina Barbara
    Raspagliesi, Francesco
    Lambaudie, Eric
    Bahrehmand, Kiarash
    Andress, Juergen
    Klat, Jaroslav
    Pasternak, Jana
    Matylevich, Olga
    Szeterlak, Nina
    Minar, Lubos
    Heitz, Florian
    Capilna, Mihai Emil
    Runnebaum, Ingo
    Cibula, David
    Slama, Jiri
    GYNECOLOGIC ONCOLOGY, 2024, 190 : 179 - 185
  • [48] Fertility-sparing surgery in patients with cervical cancer
    Rob, Lukas
    Skapa, Petr
    Robova, Helena
    LANCET ONCOLOGY, 2011, 12 (02) : 192 - 200
  • [49] Conservative management of early stage cervical cancer: Is there a role for less radical surgery?
    Schmeler, Kathleen M.
    Frumovitz, Michael
    Ramirez, Pedro T.
    GYNECOLOGIC ONCOLOGY, 2011, 120 (03) : 321 - 325
  • [50] Evaluation of reproductive and oncological outcomes after fertility-sparing surgery in cervical cancer patients with tumor > 2 cm
    Bahrehmand, Kiarash
    Vesztergom, Dora
    Budai, Barna
    Lengyel, Daniel
    Lukacs, Edina
    Novak, Zoltan
    GYNECOLOGIC ONCOLOGY REPORTS, 2025, 57